Breast Cancer
Mindpeak's artificial intelligence-based technology can be integrated with lab workflow software to automate pathology.
Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications
Premium
The company failed in its first bid for breakthrough device designation but has now split out new specific indications for which it is building more persuasive utility data.
The research team drew on the idea that cancerous lymphatic fluid in the breast is less electrically conductive to create a test diagnosing breast cancer.
Exai Bio Raises $67.5M in Series A Round for Liquid Biopsy Early Cancer Detection Platform
The blood-based platform uses AI and machine learning algorithms to analyze cell-free RNA profiles, with a focus on orphan noncoding RNA.
Agilent Gets CE Mark for Expanded Use of PD-L1 CDx in Triple-Negative Breast Cancer
The CDx, developed by Agilent and Merck, can now be used as an aid in identifying triple-negative breast cancer patients for treatment with pembrolizumab in the European Union.